ABSTRACT
OBJECTIVE: Schizophrenia seriously degrades the ability to function normally in those who suffer from this disease. The purpose of this study was to develop a comprehensive online medication adherence enhancement program and to test its effectiveness among schizophrenia patients who live in community relatively neglected with few inputs or oversights from community mental health centers. METHODS: A nonequivalent control group with prepost test was employed during the study. Participants included fifty-two chronic schizophrenia patients, twentysix experimental, and a control group of twenty-six. The study variables were medication knowledge, perceived benefits, self efficacy, social support and medication compliance. RESULTS: There were significant differences between two groups in perceived benefits (F=5.67, p=0.02), self-efficacy (F=6.38, p=0.01), social support (F=14.63, p<0.001) but no significant differences in medication knowledge (F=0.82, p=0.37), and medication compliance (F=0.89, p=0.35) when the program was completed. However, medication knowledge in posttest I and posttest II which was taken after 3 months of the program were significantly increased in the experimental group (F=8.88, p<0.001). Medication adherence in posttest II was significantly increased in the experimental group (F=6.10, p<0.001). CONCLUSION: The online medication adherence enhancement program for persons with schizophrenia was effective at increasing psychosocial variables such as perceived benefits, self efficacy, and social support. This program can be used for schizophrenic persons in community mental health centers, patients' homes, hospitals, and community centers.